Cash and Cash Equivalents, at Carrying Value of Traws Pharma, Inc. from 31 Dec 2010 to 31 Dec 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
Summary
Traws Pharma, Inc. quarterly Cash and Cash Equivalents, at Carrying Value in USD history and change rate from 31 Dec 2010 to 31 Dec 2023.
  • Traws Pharma, Inc. Cash and Cash Equivalents, at Carrying Value for the quarter ending 31 Dec 2023 was $20,559,000, a 47% decline year-over-year.
Source SEC data
View on sec.gov
Cash and Cash Equivalents, at Carrying Value, Quarterly (USD)
Cash and Cash Equivalents, at Carrying Value, YoY Quarterly Change (%)

Traws Pharma, Inc. Quarterly Cash and Cash Equivalents, at Carrying Value (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2023 $20,559,000 -$17,963,000 -47% 31 Dec 2023 10-K 01 Apr 2024 2023 FY
Q4 2022 $38,522,000 31 Dec 2022 10-K 30 Mar 2023 2022 FY
Q3 2017 $7,600,000 -$18,178,000 -71% 30 Sep 2017 10-Q 09 Nov 2017 2017 Q3
Q2 2017 $14,989,000 +$2,171,000 +17% 30 Jun 2017 10-Q 14 Aug 2017 2017 Q2
Q1 2017 $15,389,000 -$1,446,000 -8.6% 31 Mar 2017 10-Q 15 May 2017 2017 Q1
Q4 2016 $21,400,000 +$1,601,000 +8.1% 31 Dec 2016 10-Q 09 Nov 2017 2017 Q3
Q3 2016 $25,778,000 +$3,581,000 +16% 30 Sep 2016 10-Q 09 Nov 2017 2017 Q3
Q2 2016 $12,818,000 -$12,540,000 -49% 30 Jun 2016 10-Q 14 Aug 2017 2017 Q2
Q1 2016 $16,835,000 -$16,863,000 -50% 31 Mar 2016 10-Q 15 May 2017 2017 Q1
Q4 2015 $19,799,000 -$23,783,000 -55% 31 Dec 2015 10-Q 09 Nov 2017 2017 Q3
Q3 2015 $22,197,000 -$20,151,000 -48% 30 Sep 2015 10-Q 14 Nov 2016 2016 Q3
Q2 2015 $25,358,000 -$30,141,000 -54% 30 Jun 2015 10-Q 15 Aug 2016 2016 Q2
Q1 2015 $33,698,000 -$20,926,000 -38% 31 Mar 2015 10-Q 11 May 2016 2016 Q1
Q4 2014 $43,582,000 -$16,427,000 -27% 31 Dec 2014 10-K 29 Mar 2017 2016 FY
Q3 2014 $42,348,000 -$34,264,000 -45% 30 Sep 2014 10-Q 12 Nov 2015 2015 Q3
Q2 2014 $55,499,000 +$4,318,000 +8.4% 30 Jun 2014 10-Q 13 Aug 2015 2015 Q2
Q1 2014 $54,624,000 -$12,683,000 -19% 31 Mar 2014 10-Q 15 May 2015 2015 Q1
Q4 2013 $60,009,000 -$21,518,000 -26% 31 Dec 2013 10-K 28 Mar 2016 2015 FY
Q3 2013 $76,612,000 -$31,536,000 -29% 30 Sep 2013 10-Q 14 Nov 2014 2014 Q3
Q2 2013 $51,181,000 +$48,659,000 +1929% 30 Jun 2013 10-Q 14 Aug 2014 2014 Q2
Q1 2013 $67,307,000 31 Mar 2013 10-Q 15 May 2014 2014 Q1
Q4 2012 $81,527,000 +$78,814,000 +2905% 31 Dec 2012 10-K 30 Mar 2015 2014 FY
Q3 2012 $108,148,000 30 Sep 2012 10-Q 14 Nov 2013 2013 Q3
Q2 2012 $2,522,000 30 Jun 2012 10-Q 06 Sep 2013 2013 Q2
Q4 2011 $2,713,000 -$4,627,000 -63% 31 Dec 2011 10-K 30 Mar 2015 2014 FY
Q4 2010 $7,340,000 31 Dec 2010 10-K 20 Mar 2014 2013 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.